C 35 (Nevirapine 200 mg)

Pill imprint C 35 has been identified as Nevirapine 200 mg.

Nevirapine is used in the treatment of reduction of perinatal transmission of hiv; hiv infection and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for C 35

Nevirapine
Imprint:
C 35
Strength:
200 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
NNRTIs
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Aurobindo Pharma Limited

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)